|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
104.18(B) |
Last
Volume: |
7,452,079 |
Avg
Vol: |
8,468,109 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
121,151 |
402,184 |
842,880 |
1,886,883 |
Total Sell Value |
$8,291,512 |
$23,867,729 |
$47,173,675 |
$92,951,291 |
Total People Sold |
6 |
8 |
10 |
13 |
Total Sell Transactions |
12 |
22 |
38 |
72 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
AS |
$46.32 |
$107,138 |
D/D |
(2,313) |
91,819 |
|
17% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
D |
$46.23 |
$59,128 |
D/D |
(1,279) |
94,132 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,804 |
95,411 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-21 |
4 |
D |
$46.23 |
$45,906 |
D/D |
(993) |
64,982 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
65,975 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-02-21 |
4 |
D |
$46.23 |
$31,945 |
D/D |
(691) |
93,899 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,558 |
94,590 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-21 |
4 |
D |
$46.23 |
$344,968 |
D/D |
(7,462) |
1,850,840 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,825 |
1,858,302 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-02-21 |
4 |
D |
$46.23 |
$75,078 |
D/D |
(1,624) |
285,958 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,661 |
287,582 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-21 |
4 |
D |
$46.23 |
$23,023 |
D/D |
(498) |
38,403 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,091 |
38,901 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-18 |
4 |
D |
$46.54 |
$46,633 |
D/D |
(1,002) |
92,607 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,817 |
93,609 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-18 |
4 |
D |
$46.54 |
$25,178 |
D/D |
(541) |
37,810 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,186 |
38,351 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-18 |
4 |
D |
$46.54 |
$53,940 |
D/D |
(1,159) |
64,261 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,001 |
65,420 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-18 |
4 |
D |
$46.54 |
$85,122 |
D/D |
(1,829) |
218,305 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
220,134 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-18 |
4 |
D |
$46.54 |
$10,146 |
D/D |
(218) |
41,101 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
741 |
41,319 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-18 |
4 |
D |
$46.54 |
$336,624 |
D/D |
(7,233) |
1,841,477 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,307 |
1,848,710 |
|
- |
|
4511 Records found
|
|
Page 10 of 181 |
|
|